金屬硫蛋白1(MT1)重組蛋白
Recombinant Metallothionein 1 (MT1)
MT1A; MT1S; MTC
- 編號(hào)URPB119Ra02
- 物種Rattus norvegicus (Rat，大鼠) 相同的名稱，不同的物種。
- 來源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測(cè)定)
- 亞細(xì)胞定位細(xì)胞核
- 預(yù)測(cè)分子量9.6kDa
- 實(shí)際分子量17kDa(差異分析請(qǐng)參閱說明書)
- 片段與標(biāo)簽Met1~Ala61 with N-terminal His Tag
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液（pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300）
- 性狀凍干粉
- 純度> 90%
- 等電點(diǎn)8.0
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請(qǐng)參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 516 ¥ 1290 ¥ 2580 ¥ 7740 ¥ 19350
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Figure. SDS-PAGE
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過一個(gè)月，-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Rattus norvegicus (Rat，大鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| UNPB119Ra01 | 金屬硫蛋白1(MT1)天然蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPB119Ra02 | 金屬硫蛋白1(MT1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPB119Ra01 | 金屬硫蛋白1(MT1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAB119Ra02 | 金屬硫蛋白1(MT1)多克隆抗體 | IHC; ICC/IF |
| UPAB119Ra01 | 金屬硫蛋白1(MT1)多克隆抗體 | IHC |
| UMAB119Ra21 | 金屬硫蛋白1(MT1)單克隆抗體 | WB; IHC; ICC; IP. |
| USEB119Ra | 金屬硫蛋白1(MT1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| ULMB119Ra | 金屬硫蛋白1(MT1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Biotechology letters | Modulated expression of genes associated with NO signal transduction contributes to the cholesterol-lowering effect of electro-acupuncture [SpringerLink: c1v4234150886817] |
| International Journal of Diabetes in Developing Countries | Evaluation of serum metallothionein-1, selenium, zinc, and copper in Ghanaian type 2 diabetes mellitus patients [Springer: Source] |
| Experimental Oncology | Peculiarities of antioxidant system and iron metabolism in organism during development of tumor resistance to cisplatin [Pubmed:25265354] |
| Journal of Neurochemistry | Neuroprotective?effects?of?levetiracetam?target?xCT?in?astrocytes?in?parkinsonian?mice. [Pubmed:26485447] |
| Toxicology Mechanisms and Methods | Evaluation of hepatorenal impairments in Wistar rats coexposed to low-dose lead, cadmium and manganese: insights into oxidative stress mechanism [pubmed:27599793] |
| Environmental toxicology and pharmacology | Dyslipdemia induced by chronic low dose co-exposure to lead, cadmium and manganese in rats: the role of oxidative stress [pubmed:28654832] |
| European?Journal?of?Immunology | Metallothionein‐1 suppresses rheumatoid arthritis pathogenesis by shifting the Th17/Treg balance [Pubmed:30055006] |
| Int Immunopharmacol | Metallothionein-1 is associated with osteoarthritis disease activity and suppresses proinflammatory cytokines production in synovial cells [Pubmed: 31465913] |
| Influence of cadmium on blood and hair trace elements and biochemical markers [] |
留言咨詢
